25 XP   0   0   10

Cellebrite DI
Buy, Hold or Sell?

Let's analyse Cellebrite together

PenkeI guess you are interested in Cellebrite DI. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cellebrite DI. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Cellebrite DI

I send you an email if I find something interesting about Cellebrite DI.

Quick analysis of Cellebrite (30 sec.)










What can you expect buying and holding a share of Cellebrite? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
26.7%

What is your share worth?

Current worth
$0.17
Expected worth in 1 year
$-0.03
How sure are you?
66.7%

+ What do you gain per year?

Total Gains per Share
$-0.19
Return On Investment
-1.8%

For what price can you sell your share?

Current Price per Share
$10.71
Expected price per share
$8.85 - $12.18
How sure are you?
50%

1. Valuation of Cellebrite (5 min.)




Live pricePrice per Share (EOD)

$10.71

Intrinsic Value Per Share

$3.77 - $4.43

Total Value Per Share

$3.94 - $4.60

2. Growth of Cellebrite (5 min.)




Is Cellebrite growing?

Current yearPrevious yearGrowGrow %
How rich?$34.2m$36.2m$4.6m11.3%

How much money is Cellebrite making?

Current yearPrevious yearGrowGrow %
Making money-$8.3m$30.2m-$38.5m-461.5%
Net Profit Margin-10.2%46.6%--

How much money comes from the company's main activities?

3. Financial Health of Cellebrite (5 min.)




What can you expect buying and holding a share of Cellebrite? (5 min.)

Welcome investor! Cellebrite's management wants to use your money to grow the business. In return you get a share of Cellebrite.

What can you expect buying and holding a share of Cellebrite?

First you should know what it really means to hold a share of Cellebrite. And how you can make/lose money.

Speculation

The Price per Share of Cellebrite is $10.71. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cellebrite.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cellebrite, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.17. Based on the TTM, the Book Value Change Per Share is $-0.05 per quarter. Based on the YOY, the Book Value Change Per Share is $0.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cellebrite.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.07-0.7%-0.08-0.8%0.141.3%0.040.4%0.040.4%
Usd Book Value Change Per Share-0.02-0.2%-0.05-0.5%0.181.7%0.010.1%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.131.2%0.131.2%
Usd Total Gains Per Share-0.02-0.2%-0.05-0.5%0.181.7%0.141.3%0.141.3%
Usd Price Per Share8.66-7.40-4.95-6.46-6.46-
Price to Earnings Ratio-30.35-1.75-13.59--146.90--146.90-
Price-to-Total Gains Ratio-476.64--141.95-33.81--17.27--17.27-
Price to Book Ratio51.97-48.62--9.58-14.06-14.06-
Price-to-Total Gains Ratio-476.64--141.95-33.81--17.27--17.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share10.71
Number of shares93
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.13
Usd Book Value Change Per Share-0.050.01
Usd Total Gains Per Share-0.050.14
Gains per Quarter (93 shares)-4.4913.11
Gains per Year (93 shares)-17.9652.45
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-18-2848442
20-36-4697894
30-54-6414512146
40-72-8219317198
50-90-10024221250
60-108-11829025302
70-126-13633829354
80-144-15438733406
90-162-17243537458
100-180-19048341510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%8.04.00.066.7%10.05.00.066.7%10.05.00.066.7%10.05.00.066.7%
Book Value Change Per Share1.02.01.025.0%7.03.02.058.3%8.03.04.053.3%8.03.04.053.3%8.03.04.053.3%
Dividend per Share0.00.04.00.0%3.00.09.025.0%4.00.011.026.7%4.00.011.026.7%4.00.011.026.7%
Total Gains per Share1.02.01.025.0%8.03.01.066.7%10.03.02.066.7%10.03.02.066.7%10.03.02.066.7%

Fundamentals of Cellebrite

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.

Fundamental data was last updated by Penke on 2024-04-21 22:57:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Cellebrite DI.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cellebrite earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cellebrite to the Software - Infrastructure industry mean.
  • A Net Profit Margin of -15.7% means that $-0.16 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cellebrite DI:

  • The MRQ is -15.7%. The company is making a huge loss. -2
  • The TTM is -10.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-15.7%TTM-10.2%-5.6%
TTM-10.2%YOY46.6%-56.8%
TTM-10.2%5Y18.6%-28.8%
5Y18.6%10Y18.6%0.0%
1.1.2. Return on Assets

Shows how efficient Cellebrite is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cellebrite to the Software - Infrastructure industry mean.
  • -2.7% Return on Assets means that Cellebrite generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cellebrite DI:

  • The MRQ is -2.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.7%TTM-1.8%-0.9%
TTM-1.8%YOY9.0%-10.8%
TTM-1.8%5Y3.4%-5.2%
5Y3.4%10Y3.4%0.0%
1.1.3. Return on Equity

Shows how efficient Cellebrite is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cellebrite to the Software - Infrastructure industry mean.
  • -42.8% Return on Equity means Cellebrite generated $-0.43 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cellebrite DI:

  • The MRQ is -42.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -50.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-42.8%TTM-50.1%+7.3%
TTM-50.1%YOY47.4%-97.5%
TTM-50.1%5Y0.6%-50.7%
5Y0.6%10Y0.6%0.0%

1.2. Operating Efficiency of Cellebrite DI.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cellebrite is operating .

  • Measures how much profit Cellebrite makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cellebrite to the Software - Infrastructure industry mean.
  • An Operating Margin of 16.1% means the company generated $0.16  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cellebrite DI:

  • The MRQ is 16.1%. The company is operating efficient. +1
  • The TTM is 12.8%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ16.1%TTM12.8%+3.3%
TTM12.8%YOY-0.1%+12.9%
TTM12.8%5Y6.9%+5.9%
5Y6.9%10Y6.9%0.0%
1.2.2. Operating Ratio

Measures how efficient Cellebrite is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Software - Infrastructure industry mean).
  • An Operation Ratio of 0.84 means that the operating costs are $0.84 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cellebrite DI:

  • The MRQ is 0.839. The company is less efficient in keeping operating costs low.
  • The TTM is 0.872. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.839TTM0.872-0.033
TTM0.872YOY1.001-0.129
TTM0.8725Y0.931-0.059
5Y0.93110Y0.9310.000

1.3. Liquidity of Cellebrite DI.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cellebrite is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Software - Infrastructure industry mean).
  • A Current Ratio of 1.64 means the company has $1.64 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cellebrite DI:

  • The MRQ is 1.641. The company is able to pay all its short-term debts. +1
  • The TTM is 1.591. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.641TTM1.591+0.050
TTM1.591YOY1.406+0.185
TTM1.5915Y1.362+0.229
5Y1.36210Y1.3620.000
1.3.2. Quick Ratio

Measures if Cellebrite is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cellebrite to the Software - Infrastructure industry mean.
  • A Quick Ratio of 1.94 means the company can pay off $1.94 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cellebrite DI:

  • The MRQ is 1.945. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.944. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.945TTM1.944+0.001
TTM1.944YOY1.589+0.355
TTM1.9445Y1.461+0.483
5Y1.46110Y1.4610.000

1.4. Solvency of Cellebrite DI.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cellebrite assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cellebrite to Software - Infrastructure industry mean.
  • A Debt to Asset Ratio of 0.94 means that Cellebrite assets are financed with 93.7% credit (debt) and the remaining percentage (100% - 93.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cellebrite DI:

  • The MRQ is 0.937. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.908. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.937TTM0.908+0.029
TTM0.908YOY0.903+0.005
TTM0.9085Y0.821+0.087
5Y0.82110Y0.8210.000
1.4.2. Debt to Equity Ratio

Measures if Cellebrite is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cellebrite to the Software - Infrastructure industry mean.
  • A Debt to Equity ratio of 1,479.6% means that company has $14.80 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cellebrite DI:

  • The MRQ is 14.796. The company is unable to pay all its debts with equity. -1
  • The TTM is 13.521. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ14.796TTM13.521+1.274
TTM13.521YOY5.473+8.049
TTM13.5215Y5.944+7.577
5Y5.94410Y5.9440.000

2. Market Valuation of Cellebrite DI

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cellebrite generates.

  • Above 15 is considered overpriced but always compare Cellebrite to the Software - Infrastructure industry mean.
  • A PE ratio of -30.35 means the investor is paying $-30.35 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cellebrite DI:

  • The EOD is -37.529. Based on the earnings, the company is expensive. -2
  • The MRQ is -30.345. Based on the earnings, the company is expensive. -2
  • The TTM is 1.749. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-37.529MRQ-30.345-7.183
MRQ-30.345TTM1.749-32.095
TTM1.749YOY13.594-11.844
TTM1.7495Y-146.899+148.648
5Y-146.89910Y-146.8990.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cellebrite DI:

  • The EOD is 14.138. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 11.431. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 14.616. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD14.138MRQ11.431+2.706
MRQ11.431TTM14.616-3.185
TTM14.616YOY-35.721+50.337
TTM14.6165Y-27.638+42.255
5Y-27.63810Y-27.6380.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cellebrite is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Software - Infrastructure industry mean).
  • A PB ratio of 51.97 means the investor is paying $51.97 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cellebrite DI:

  • The EOD is 64.268. Based on the equity, the company is expensive. -2
  • The MRQ is 51.966. Based on the equity, the company is expensive. -2
  • The TTM is 48.620. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD64.268MRQ51.966+12.301
MRQ51.966TTM48.620+3.346
TTM48.620YOY-9.585+58.205
TTM48.6205Y14.060+34.561
5Y14.06010Y14.0600.000
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cellebrite DI.

3.1. Institutions holding Cellebrite DI

Institutions are holding 42.476% of the shares of Cellebrite DI.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Igp Investments (GPLP) Lp10.684595.527521087692210876920
2023-12-31True Wind Capital Management, L.P.6.78334.35711338750000
2023-12-31Clal Insurance Enterprises Holdings Ltd3.59030.738870861585148587.8349
2023-12-31Phoenix Holdings Ltd2.05470.65444055330-7992862-66.3408
2023-12-31Nine Ten Capital Management LLC1.87788.071237061982639596247.4771
2023-12-31Morgan Stanley - Brokerage Accounts1.82980.00283611371127647854.6697
2023-12-31Crosslink Capital Inc1.64184.16653240480445201.393
2023-12-31Greenhaven Road Investment Management, L.P.1.448210.90972858268-3486946-54.954
2023-12-31Acadian Asset Management LLC1.15710.0766228371063723038.7026
2023-12-31Voss Capital LLC0.92971.547418350001238580207.6691
2023-12-31Millennium Management LLC0.9160.0068180783572632267.158
2023-12-31Ashford Capital Management Inc0.75551.7299149110014911000
2023-12-31Arrowstreet Capital Limited Partnership0.6640.0119131059642750748.4104
2023-12-31Two Sigma Investments LLC0.65810.02581298802943089265.1264
2023-12-31Isomer Partners LP0.61814.77481220000-430000-26.0606
2023-12-31Two Sigma Advisers, LLC0.59730.02391178900827700235.6777
2023-12-31BlackRock Inc0.56570.0003111656143361663.4921
2023-12-31Renaissance Technologies Corp0.53260.01411051156727756225.0328
2023-12-31Marshall Wace Asset Management Ltd0.45540.013289885740145480.71
2023-12-31Light Street Capital Management LLC0.40032.0487789966-1267833-61.6111
Total 38.1599164.701475315480+20239857+26.9%

3.2. Funds holding Cellebrite DI

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Ashford Small Company Growth0.38043.432875074013014020.97
2024-03-31Royce Micro Cap Trust0.36181.466871410000
2024-03-31BlackRock Global Equity Mkt Netrl Instl0.21170.33374177546655018.9491
2024-03-28iShares Core MSCI EAFE ETF0.14140.002727909600
2024-03-31ARK Israel Innovative Technology ETF0.13052.609625750000
2024-03-28iShares MSCI EAFE Small-Cap ETF0.08560.019116895000
2023-12-31CIBC Dividend Growth0.08520.256116815800
2023-12-31Acadian Non-US Small-Cap Developed Eqty0.08280.06281634675734754.0398
2023-12-31BGF Systmtc Sust Glb SmallCap A20.07820.50271544384034335.3591
2024-03-31State St Gbl Sm Cp Eq ex-US Indx NL Cl A0.0650.014312830097008.1788
2024-02-29Fidelity Nasdaq Composite Index0.05950.00911746500
2024-03-31Royce Global Value Trust0.0411.1163808683426873.5365
2024-03-28Inspire Fidelis Multi Factor ETF0.03940.9687779123913.1711
2024-03-31Sydinvest Megatrends Akk A0.0390.78077690714881.973
2024-03-28BlueStar Israel Technology ETF0.02990.75065898800
2024-03-31State St Gbl All Cp Eq ex-US Idx NL Cl K0.02990.0025891842407.7545
2023-12-31Acadian International Sm-Cp Eq CIT A0.02840.16845613500
2023-12-31Acadian ACW ex-U.S. Equity Composite0.02740.0282540581684345.2586
2023-12-31Sydinvest Megatrends Udb A0.02690.541253074499810.396
2023-12-31NT Dev Intl SM Idx Fd - NL0.02440.0193482322133279.3011
Total 1.968413.08433884939+389640+10.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Cellebrite DI compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.018-0.048+166%0.179-110%0.011-264%0.011-264%
Book Value Per Share--0.1670.199-16%0.177-6%0.101+65%0.101+65%
Current Ratio--1.6411.591+3%1.406+17%1.362+20%1.362+20%
Debt To Asset Ratio--0.9370.908+3%0.903+4%0.821+14%0.821+14%
Debt To Equity Ratio--14.79613.521+9%5.473+170%5.944+149%5.944+149%
Dividend Per Share----0%-0%0.130-100%0.130-100%
Eps---0.071-0.082+15%0.143-150%0.040-280%0.040-280%
Free Cash Flow Per Share--0.1890.140+35%0.014+1253%0.073+160%0.073+160%
Free Cash Flow To Equity Per Share--0.2110.166+27%0.031+582%0.063+237%0.063+237%
Gross Profit Margin--3.020-0.158+105%-0.383+113%-1.303+143%-1.303+143%
Intrinsic Value_10Y_max--4.434--------
Intrinsic Value_10Y_min--3.773--------
Intrinsic Value_1Y_max--0.283--------
Intrinsic Value_1Y_min--0.278--------
Intrinsic Value_3Y_max--0.974--------
Intrinsic Value_3Y_min--0.927--------
Intrinsic Value_5Y_max--1.812--------
Intrinsic Value_5Y_min--1.672--------
Market Cap2198730784.320+19%1777871950.7201519197740.800+17%1015193625.440+75%1327039756.288+34%1327039756.288+34%
Net Profit Margin---0.157-0.102-35%0.466-134%0.186-185%0.186-185%
Operating Margin--0.1610.128+26%-0.001+101%0.069+133%0.069+133%
Operating Ratio--0.8390.872-4%1.001-16%0.931-10%0.931-10%
Pb Ratio64.268+19%51.96648.620+7%-9.585+118%14.060+270%14.060+270%
Pe Ratio-37.529-24%-30.3451.749-1835%13.594-323%-146.899+384%-146.899+384%
Price Per Share10.710+19%8.6607.400+17%4.945+75%6.464+34%6.464+34%
Price To Free Cash Flow Ratio14.138+19%11.43114.616-22%-35.721+412%-27.638+342%-27.638+342%
Price To Total Gains Ratio-589.472-24%-476.641-141.951-70%33.807-1510%-17.269-96%-17.269-96%
Quick Ratio--1.9451.944+0%1.589+22%1.461+33%1.461+33%
Return On Assets---0.027-0.018-34%0.090-130%0.034-180%0.034-180%
Return On Equity---0.428-0.501+17%0.474-190%0.006-6706%0.006-6706%
Total Gains Per Share---0.018-0.048+166%0.179-110%0.141-113%0.141-113%
Usd Book Value--34212000.00040893750.000-16%36290750.000-6%20705400.000+65%20705400.000+65%
Usd Book Value Change Per Share---0.018-0.048+166%0.179-110%0.011-264%0.011-264%
Usd Book Value Per Share--0.1670.199-16%0.177-6%0.101+65%0.101+65%
Usd Dividend Per Share----0%-0%0.130-100%0.130-100%
Usd Eps---0.071-0.082+15%0.143-150%0.040-280%0.040-280%
Usd Free Cash Flow--38881000.00028823000.000+35%2873000.000+1253%14982000.000+160%14982000.000+160%
Usd Free Cash Flow Per Share--0.1890.140+35%0.014+1253%0.073+160%0.073+160%
Usd Free Cash Flow To Equity Per Share--0.2110.166+27%0.031+582%0.063+237%0.063+237%
Usd Market Cap2198730784.320+19%1777871950.7201519197740.800+17%1015193625.440+75%1327039756.288+34%1327039756.288+34%
Usd Price Per Share10.710+19%8.6607.400+17%4.945+75%6.464+34%6.464+34%
Usd Profit---14647000.000-8354250.000-43%30201250.000-148%11454800.000-228%11454800.000-228%
Usd Revenue--93013000.00081973500.000+13%67662750.000+37%66731333.333+39%66731333.333+39%
Usd Total Gains Per Share---0.018-0.048+166%0.179-110%0.141-113%0.141-113%
 EOD+4 -4MRQTTM+23 -11YOY+15 -195Y+17 -1910Y+17 -19

4.2. Fundamental Score

Let's check the fundamental score of Cellebrite DI based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-37.529
Price to Book Ratio (EOD)Between0-164.268
Net Profit Margin (MRQ)Greater than0-0.157
Operating Margin (MRQ)Greater than00.161
Quick Ratio (MRQ)Greater than11.945
Current Ratio (MRQ)Greater than11.641
Debt to Asset Ratio (MRQ)Less than10.937
Debt to Equity Ratio (MRQ)Less than114.796
Return on Equity (MRQ)Greater than0.15-0.428
Return on Assets (MRQ)Greater than0.05-0.027
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Cellebrite DI based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.115
Ma 20Greater thanMa 5010.824
Ma 50Greater thanMa 10011.234
Ma 100Greater thanMa 2009.939
OpenGreater thanClose10.740
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets540,397
Total Liabilities506,185
Total Stockholder Equity34,212
 As reported
Total Liabilities 506,185
Total Stockholder Equity+ 34,212
Total Assets = 540,397

Assets

Total Assets540,397
Total Current Assets416,532
Long-term Assets123,865
Total Current Assets
Cash And Cash Equivalents 189,517
Short-term Investments 113,406
Net Receivables 77,269
Inventory 10,538
Other Current Assets 25,802
Total Current Assets  (as reported)416,532
Total Current Assets  (calculated)416,532
+/-0
Long-term Assets
Property Plant Equipment 30,156
Goodwill 26,829
Long Term Investments 28,859
Intangible Assets 10,594
Long-term Assets Other 12,891
Long-term Assets  (as reported)123,865
Long-term Assets  (calculated)109,329
+/- 14,536

Liabilities & Shareholders' Equity

Total Current Liabilities253,824
Long-term Liabilities252,361
Total Stockholder Equity34,212
Total Current Liabilities
Short-term Debt 4,972
Accounts payable 8,282
Other Current Liabilities 43,983
Total Current Liabilities  (as reported)253,824
Total Current Liabilities  (calculated)57,237
+/- 196,587
Long-term Liabilities
Capital Lease Obligations 14,129
Long-term Liabilities Other 134,477
Long-term Liabilities  (as reported)252,361
Long-term Liabilities  (calculated)148,606
+/- 103,755
Total Stockholder Equity
Retained Earnings 118,143
Accumulated Other Comprehensive Income 1,050
Other Stockholders Equity -84,981
Total Stockholder Equity (as reported)34,212
Total Stockholder Equity (calculated)34,212
+/-0
Other
Cash and Short Term Investments 302,923
Common Stock Shares Outstanding 194,441
Current Deferred Revenue196,587
Liabilities and Stockholders Equity 540,397
Net Debt -175,388
Net Invested Capital 34,212
Net Working Capital 168,258
Property Plant and Equipment Gross 63,409
Short Long Term Debt Total 14,129



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
364,387
0
369,906
315,149
339,783
324,625
324,842
352,494
403,293
403,293
425,893
476,942
540,397
540,397476,942425,893403,293403,293352,494324,842324,625339,783315,149369,9060364,387000
   > Total Current Assets 
0
0
0
324,270
316,328
322,061
271,328
273,212
250,134
233,642
262,504
295,931
295,931
337,405
374,310
416,532
416,532374,310337,405295,931295,931262,504233,642250,134273,212271,328322,061316,328324,270000
       Cash And Cash Equivalents 
0
0
0
128,709
0
166,286
109,886
145,973
125,719
91,685
84,566
87,645
87,645
110,502
137,066
189,517
189,517137,066110,50287,64587,64584,56691,685125,719145,973109,886166,2860128,709000
       Short-term Investments 
0
0
0
108,928
0
79,848
61,801
35,592
40,208
50,829
61,970
95,978
95,978
126,756
126,674
113,406
113,406126,674126,75695,97895,97861,97050,82940,20835,59261,80179,8480108,928000
       Net Receivables 
0
0
0
66,324
59,585
52,283
76,215
67,505
60,297
66,746
88,581
78,761
78,761
61,194
69,559
77,269
77,26969,55961,19478,76178,76188,58166,74660,29767,50576,21552,28359,58566,324000
       Other Current Assets 
0
0
0
2,957
8,249
9,919
14,055
12,818
16,052
16,266
18,037
17,085
17,085
22,185
24,476
25,802
25,80224,47622,18517,08517,08518,03716,26616,05212,81814,0559,9198,2492,957000
   > Long-term Assets 
0
0
0
40,117
0
47,845
43,821
66,571
74,491
91,200
89,990
107,362
107,362
88,488
102,632
123,865
123,865102,63288,488107,362107,36289,99091,20074,49166,57143,82147,845040,117000
       Property Plant Equipment 
0
0
0
16,106
16,285
16,608
16,392
16,756
17,752
17,775
17,634
32,912
32,912
29,955
27,981
30,156
30,15627,98129,95532,91232,91217,63417,77517,75216,75616,39216,60816,28516,106000
       Goodwill 
0
0
0
9,463
0
9,463
9,463
26,829
26,829
26,829
26,829
26,829
26,829
26,829
26,829
26,829
26,82926,82926,82926,82926,82926,82926,82926,82926,8299,4639,46309,463000
       Long Term Investments 
0
0
0
0
0
0
0
0
6,475
25,335
21,266
22,125
18,521
7,297
19,494
28,859
28,85919,4947,29718,52122,12521,26625,3356,47500000000
       Intangible Assets 
0
0
0
6,611
0
8,788
8,312
11,228
10,564
9,901
9,808
11,254
11,254
9,618
11,155
10,594
10,59411,1559,61811,25411,2549,8089,90110,56411,2288,3128,78806,611000
       Other Assets 
0
0
0
0
10,579
12,986
9,654
11,758
12,871
13,864
14,453
14,242
0
14,789
17,173
0
017,17314,789014,24214,45313,86412,87111,7589,65412,98610,5790000
> Total Liabilities 
0
0
0
300,583
0
292,338
445,133
413,132
336,846
300,784
293,033
329,428
329,428
408,337
439,000
506,185
506,185439,000408,337329,428329,428293,033300,784336,846413,132445,133292,3380300,583000
   > Total Current Liabilities 
0
0
0
159,382
147,906
151,194
403,720
186,573
170,556
172,873
189,782
207,777
207,777
204,506
226,838
253,824
253,824226,838204,506207,777207,777189,782172,873170,556186,573403,720151,194147,906159,382000
       Short-term Debt 
0
0
0
6,610
0
0
51,732
695
0
0
0
5,003
5,003
4,955
4,700
4,972
4,9724,7004,9555,0035,00300069551,732006,610000
       Accounts payable 
0
0
0
4,727
4,525
4,419
5,756
9,546
9,288
3,775
4,716
4,612
4,612
4,991
7,985
8,282
8,2827,9854,9914,6124,6124,7163,7759,2889,5465,7564,4194,5254,727000
       Other Current Liabilities 
0
0
0
41,943
143,381
44,448
231,215
53,349
43,483
47,453
49,424
45,453
45,453
35,618
43,494
43,983
43,98343,49435,61845,45345,45349,42447,45343,48353,349231,21544,448143,38141,943000
   > Long-term Liabilities 
0
0
0
141,201
0
141,144
41,413
226,559
166,290
127,911
103,251
121,651
121,651
203,831
212,162
252,361
252,361212,162203,831121,651121,651103,251127,911166,290226,55941,413141,1440141,201000
       Other Liabilities 
0
0
0
0
41,600
39,939
41,413
226,557
166,290
127,911
103,251
111,298
0
195,200
204,840
0
0204,840195,2000111,298103,251127,911166,290226,55741,41339,93941,6000000
> Total Stockholder Equity
0
0
0
63,804
0
77,568
-129,984
-73,349
-12,221
24,058
59,461
73,865
73,865
17,556
37,942
34,212
34,21237,94217,55673,86573,86559,46124,058-12,221-73,349-129,98477,568063,804000
   Common Stock0000000000000000
   Retained Earnings Total Equity0000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
1,321
0
110
-78
1,372
575
-1,009
-774
331
331
-483
392
1,050
1,050392-483331331-774-1,0095751,372-7811001,321000
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
34,141
397
37,730
-156,424
-153,157
-146,672
-142,006
-131,930
-125,709
-125,709
-108,251
-95,240
-84,981
-84,981-95,240-108,251-125,709-125,709-131,930-142,006-146,672-153,157-156,42437,73039734,141000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue325,110
Cost of Revenue-53,231
Gross Profit271,879271,879
 
Operating Income (+$)
Gross Profit271,879
Operating Expense-238,597
Operating Income33,28233,282
 
Operating Expense (+$)
Research Development84,386
Selling General Administrative43,443
Selling And Marketing Expenses110,813
Operating Expense238,597238,642
 
Net Interest Income (+$)
Interest Income8,888
Interest Expense-753
Other Finance Cost-91,008
Net Interest Income-82,873
 
Pretax Income (+$)
Operating Income33,282
Net Interest Income-82,873
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-75,563142,127
EBIT - interestExpense = 32,529
-75,563
-80,347
Interest Expense753
Earnings Before Interest and Taxes (EBIT)33,282-74,810
Earnings Before Interest and Taxes (EBITDA)43,293
 
After tax Income (+$)
Income Before Tax-75,563
Tax Provision-5,259
Net Income From Continuing Ops-59,375-80,822
Net Income-81,100
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses291,828
Total Other Income/Expenses Net-108,84582,873
 

Technical Analysis of Cellebrite
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cellebrite. The general trend of Cellebrite is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cellebrite's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cellebrite DI.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 11.25 < 11.26 < 12.18.

The bearish price targets are: 9.57 > 8.91 > 8.85.

Tweet this
Cellebrite DI Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cellebrite DI. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cellebrite DI Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cellebrite DI. The current macd is -0.18281213.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cellebrite price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cellebrite. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cellebrite price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Cellebrite DI Daily Moving Average Convergence/Divergence (MACD) ChartCellebrite DI Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cellebrite DI. The current adx is 19.23.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Cellebrite shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Cellebrite DI Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cellebrite DI. The current sar is 10.28.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Cellebrite DI Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cellebrite DI. The current rsi is 46.12. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
Cellebrite DI Daily Relative Strength Index (RSI) ChartCellebrite DI Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cellebrite DI. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cellebrite price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Cellebrite DI Daily Stochastic Oscillator ChartCellebrite DI Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cellebrite DI. The current cci is -29.49518084.

Cellebrite DI Daily Commodity Channel Index (CCI) ChartCellebrite DI Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cellebrite DI. The current cmo is -5.02094074.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Cellebrite DI Daily Chande Momentum Oscillator (CMO) ChartCellebrite DI Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cellebrite DI. The current willr is -63.59832636.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Cellebrite is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Cellebrite DI Daily Williams %R ChartCellebrite DI Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cellebrite DI.

Cellebrite DI Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cellebrite DI. The current atr is 0.33549036.

Cellebrite DI Daily Average True Range (ATR) ChartCellebrite DI Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cellebrite DI. The current obv is 24,823,229.

Cellebrite DI Daily On-Balance Volume (OBV) ChartCellebrite DI Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cellebrite DI. The current mfi is 33.79.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Cellebrite DI Daily Money Flow Index (MFI) ChartCellebrite DI Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cellebrite DI.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Cellebrite DI Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cellebrite DI based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.115
Ma 20Greater thanMa 5010.824
Ma 50Greater thanMa 10011.234
Ma 100Greater thanMa 2009.939
OpenGreater thanClose10.740
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Cellebrite with someone you think should read this too:
  • Are you bullish or bearish on Cellebrite? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cellebrite? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cellebrite DI

I send you an email if I find something interesting about Cellebrite DI.


Comments

How you think about this?

Leave a comment

Stay informed about Cellebrite DI.

Receive notifications about Cellebrite DI in your mailbox!